Panbela Therapeutics
Manufacturing · Minnesota, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
712 Vista Blvd PMB 305, Waconia, Minneso...Phone Number
(952) 479-1196Website
www.panbela.comRevenue
<$5 MillionStock Symbol
PBLAIndustry
About Panbela Therapeutics
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics, Inc. is dedicated to treating patients with pancreatic cancer and exploring SBP-101's potential for efficacy in combination with other agents in other cancer indications.Explore more
SIC Code 28,283NAICS Code 32,325Ticker OTC: PBLAShow morePanbela Therapeutics Org Chart
Panbela Therapeutics Tech Stack
A closer look at the technologies used by Panbela Therapeutics
Frequently Asked Questions Regarding Panbela Therapeutics
Sign Up For FreeTo access detailed company insights
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics... Read More